Drugs

Immune Responses to Enzymes Replacement Therapies: Role of Immune Tolerance Induction

Meeting Information

Immune Responses to Enzymes Replacement Therapies: Role of Immune Tolerance Induction

The FDA in co-sponsorship with the National Organization for Rare Disorders (NORD) is announcing a 1-day public workshop. The workshop will provide a forum to discuss the role of immune tolerance induction in patients receiving replacement biological products.

Date:                              June 9, 2014
Time:                              8:00 am to 5:00 pm
Location:                        FDA White Oak Campus
                                       Bldg. 31, Great Room 1503
                                       Silver Spring, MD 20993
                                       (Information about arrival to FDA’s White Oak campus)

Registration

There is no fee to attend the public workshop, but advanced online registration is recommended.  Onsite registration is available on the day of the event but  advanced registration is preferred. To register online, please visit  https://events.rarediseases.org/?page_id=4&ee=13

The Workshop will also be available via webcast providing both audio and video broadcasting:  https://collaboration.fda.gov/immuneresponse/.

 Final agenda and slides available at the registration site:  https://events.rarediseases.org/?ee=13

Contact Information

Meeting Information

  • Federal Register Notice

 

Page Last Updated: 10/19/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English